Kriya Therapeutics announced it raised $313 Million in an initial filing from an offering of $313 Million

Company

Location

About

Kriya is a biopharmaceutical company on a mission to revolutionize medicine by developing gene therapies that aim to eliminate human suffering and free people from the burden of chronic disease. With operations in Research Triangle Park, North Carolina, and Palo Alto, California, Kriya has raised over $600 million to advance a broad pipeline of gene therapies in ophthalmology, metabolic disease, and neurology.